These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 4731236

  • 21. [Mechanism of protective action of polyvinylpyridine-N-oxide].
    Shnaĭdman IM.
    Gig Tr Prof Zabol; 1974 Jan; 18(1):19-23. PubMed ID: 4839818
    [No Abstract] [Full Text] [Related]

  • 22. The prophylactic action of polyvinylpyridine N-oxide (P 204) in silicosis. An experimental study.
    Pott F, Schlipköter HW, Brockhaus A.
    Ger Med Mon; 1969 Jul; 14(7):337-40. PubMed ID: 5820416
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Polyvinylpyridine-N-oxide. (Review)].
    Dubovik BV, Shadurskiĭ KS, Etlis VS.
    Farmakol Toksikol; 1969 Jul; 32(2):226-31. PubMed ID: 4893594
    [No Abstract] [Full Text] [Related]

  • 27. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
    Prügger F, Mallner B, Schlipköter HW.
    Wien Klin Wochenschr; 1984 Dec 07; 96(23):848-53. PubMed ID: 6396971
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Preventive and curative silicotropic effect of polyvinylpyridine-N-oxide in liver and spleen tests].
    Hennies H, Eger K, Eger W.
    Beitr Silikoseforsch; 1967 Dec 07; 93():15-32. PubMed ID: 6072453
    [No Abstract] [Full Text] [Related]

  • 31. [Polyvinylpyridine-N-oxide and experimental silicosis].
    Sklensky BS.
    Gig Tr Prof Zabol; 1969 Jun 07; 13(6):22-7. PubMed ID: 5799471
    [No Abstract] [Full Text] [Related]

  • 32. [Toxicological and pharmacological properties of polyvinyl pyridine-N-oxide with different molecular weights].
    Shadurskiĭ KS, Dubovik BV, Il'iuchenok TIu, Shevchuk AS, Lushnikova GA.
    Farmakol Toksikol; 1971 Jun 07; 34(4):485-9. PubMed ID: 5160795
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Current aspects of treatment of silicosis].
    Sidorova NV.
    Sov Med; 1974 Aug 07; 0(8):39-43. PubMed ID: 4610803
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Advances in the study of anti-silicotic agents].
    Huang FZ, Li QL, Qu SJ.
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr 07; 9(2):118-21. PubMed ID: 3527609
    [No Abstract] [Full Text] [Related]

  • 37. The protective influence of polyvinylpyridine-N-oxide in experimental silicosis.
    Cavagna G, Nichelatti T.
    Med Lav; 1963 Oct 07; 54(10):621-7. PubMed ID: 5878631
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Combined treatment of experimental silicotuberculosis with poly-2-vinylpyridine-N-oxide and isoniazid].
    Frolova NN, Ozerova LV, Mordovskoĭ GG.
    Probl Tuberk; 1975 Oct 07; (3):67-9. PubMed ID: 1135207
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.